Lixte Biotechnology Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Lixte Biotechnology Holdings, Inc. Earnings Date And Information
Lixte Biotechnology Holdings, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lixte Biotechnology Holdings, Inc. has generated $-3 earnings per share over the last year ($-2.66 diluted earnings per share) and currently has a price-to-earnings ratio of -0.94. Lixte Biotechnology Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Lixte Biotechnology Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.45 | $0 | $0 | ||
| 05/09/2024 | Q1 2024 | -$0.43 | $0 | |||
| 03/19/2024 | Q4 2023 | -$0.46 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.49 | $0 | |||
| 08/09/2023 | Q2 2023 | -$1.00 | $0 | |||
| 05/10/2023 | Q1 2023 | -$0.82 | $0 | |||
| 03/29/2023 | Q4 2022 | -$0.98 | $0 | |||
| 11/08/2022 | Q3 2022 | -$0.89 | $0 | |||
| 08/10/2022 | Q2 2022 | -$0.95 | $0 | |||
| 05/11/2022 | Q1 2022 | -$1.21 | $0 | |||
| 03/21/2022 | Q4 2021 | -$1.48 | $0 | |||
| 11/10/2021 | Q3 2021 | -$0.90 | $0 | |||
| 08/10/2021 | Q2 2021 | -$1.27 | $0 | |||
| 05/12/2021 | Q1 2021 | -$1.35 | $0 | |||
| 03/26/2021 | Q4 2020 | -$0.78 | $0 | |||
| 11/10/2020 | Q3 2020 | -$1.43 | $0 | |||
| 08/10/2020 | Q2 2020 | -$0.33 | $0 | |||
| 05/11/2020 | Q1 2020 | -$0.34 | $0 | |||
| 03/25/2020 | Q4 2019 | -$0.29 | $0 | |||
| 11/08/2019 | Q3 2019 | -$0.97 | $0 |
Lixte Biotechnology Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Lixte Biotechnology Holdings, Inc.'s earnings date?
Lixte Biotechnology Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to Lixte Biotechnology Holdings, Inc.'s earnings conference call?
The conference call for Lixte Biotechnology Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Lixte Biotechnology Holdings, Inc.'s conference call transcript?
The conference call transcript for Lixte Biotechnology Holdings, Inc.'s latest earnings report can be read online.
-
How much profit does Lixte Biotechnology Holdings, Inc. generate each year?
Lixte Biotechnology Holdings, Inc. (:LIXT) has a recorded net income of $0. Lixte Biotechnology Holdings, Inc. has generated $-2.66 earnings per share over the last four quarters.
-
What is Lixte Biotechnology Holdings, Inc.'s price-to-earnings ratio?
Lixte Biotechnology Holdings, Inc. (:LIXT) has a price-to-earnings ratio of -0.94 and price/earnings-to-growth ratio is -0.04.
